Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

1.1K
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

362
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
362
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

374
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
374
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

410
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
410
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

1.4K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.4K
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

1.2K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.2K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Investigating Titanium Fastener Technology: Results from the Multi-center Prospective CRIMP Study.

Advances in therapy·2026
Same author

Bicuspid aortic valve stenosis is characterized by increased angiogenesis, inflammation, and a higher valvular-to-systemic calcification ratio than tricuspid aortic valve stenosis.

Basic research in cardiology·2026
Same author

Coronary Artery Disease and Preoperative Coronary Angiography in Elective Thoracic Endovascular Aortic Repair: A Retrospective Cohort Study.

Journal of cardiovascular development and disease·2026
Same author

Impact of pre-existing CIED on mid-term mortality in patients undergoing TAVR.

Clinical research in cardiology : official journal of the German Cardiac Society·2026
Same author

Endoscopic minimally invasive modified Bentall procedure with sutureless valve through right anterior minithoracotomy.

JTCVS techniques·2026
Same author

Prognostic impact of iliofemoral access-site calcification volume on outcomes after transcatheter aortic valve implantation.

Clinical research in cardiology : official journal of the German Cardiac Society·2026

関連する実験動画

Updated: Mar 13, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.7K

心臓発作による急性心筋梗塞による緊急冠動脈バイパス移植後の早期および遅期の死亡率の時間的傾向

Piroze M Davierwala1, Sergey Leontyev2, Alexander Verevkin2

  • 1From Department of Cardiac Surgery, Heart Center, University of Leipzig, Leipzig, Germany (P.M.D., S.L., A.V., F.B., M. Misfeld, F.W.M.); Department of Cardiovascular Surgery, Heart and Circulatory Center, Rotenburg an der Fulda, Germany (A.J.R.); and Medizinische Klinik II, Sana Kliniken, Lübeck, Germany (M. Mohr). pirarm@hotmail.com.

Circulation
|October 26, 2016
PubMed
まとめ

心筋梗塞後の心臓発作による緊急バイパス移植は 高い死亡率がありますが 結果は時間の経過とともに改善します これらの高リスク患者の早期および遅い死亡率の主要な予測因子です.

キーワード:
冠動脈バイパス心臓発作ショック,心臓治療の結果

さらに関連する動画

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

4.6K
Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
03:13

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research

Published on: November 3, 2023

3.1K

関連する実験動画

Last Updated: Mar 13, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.7K
Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

4.6K
Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
03:13

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research

Published on: November 3, 2023

3.1K

科学分野:

  • 心臓病科
  • 心臓 外科
  • クリティカル ケア 医療

背景:

  • 心筋梗塞後の心臓発作性ショックは,皮膚経冠動脈介入が実行できない場合に緊急冠動脈バイパス移植 (CABG) を必要とします.
  • この研究では,心臓発作性ショックのために緊急CABGを受ける患者の早期および長期的なアウトカムに対するリスク要因を評価します.

研究 の 目的:

  • 心臓発作性ショックのために緊急CABGを受ける患者の入院死亡率の予測要因を特定する.
  • 心臓発作性ショックのために緊急CABGを受ける患者の長期的な死亡率の予測要因を特定する.
  • 時間の経過とともに結果の傾向を分析する.

主な方法:

  • 2000年から2014年の間に心筋血管新生性ショックのために緊急CABGを受けた508人の患者の遡及分析.
  • 患者は3つの時間コーホートに分けられた (2000 - 2004年,2005 - 2009年,2010 - 2014年).
  • 病院内および長期の死亡率の予測要因を特定するために使用されるロジスティックおよびコックス回帰分析.

主要な成果:

  • 総合的な入院死亡率は33. 7%で,研究期間中に著しく減少した (42. 2%から24. 6%).
  • 病院での死亡率の独立予測要因には,血清乳酸値> 4 mmol/ L,STセグメント上昇性心筋梗塞,年齢> 75歳,左心室排出分数< 30% が含まれていた.
  • 血清乳酸値> 4 mmol/ L,年齢増加,NYHAクラスIV,糖尿病,および手術前サポートの必要性などの遅い死亡率の予測要因で,長期生存率が改善しました.

結論:

  • 心筋梗塞後の心血管新生ショックに対する緊急CABGは,高い入院死亡率と関連しているが,結果は時間の経過とともに改善している.
  • 病院での生存者は 長期的な良好な結果を経験し,手術による再血管化の恩恵を強調しています.
  • 術前の血清乳酸値> 4 mmol/ Lは,早期および遅い死亡率の両方の有意な予測因子です.